Packages (Simulation)
Reagent Preparation
Image (I)
Image (II)
Certificate
Multiplex Assay Kit for Glypican 4 (GPC4) ,etc. by CBA (Cytometric Bead Array)
K-Glypican; Glypican Proteoglycan 4; Secreted glypican-4
- Product No.CMA998Mu
- Organism SpeciesMus musculus (Mouse) Same name, Different species.
- Sample TypeSerum, plasma, tissue homogenates and other biological fluids
- Test MethodDouble-antibody Sandwich
- Assay Length4h
- Detection Range0.9766-1000pg/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 0.3255pg/mL.
- DownloadInstruction Manual
- UOM 48T96T
- FOB
US$ 545
US$ 778
For more details, please contact local distributors!
Specificity
This assay has high sensitivity and excellent specificity for detection of Glypican 4 (GPC4) ,etc. by CBA (Cytometric Bead Array).
No significant cross-reactivity or interference between Glypican 4 (GPC4) ,etc. by CBA (Cytometric Bead Array) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Glypican 4 (GPC4) ,etc. by CBA (Cytometric Bead Array) and the recovery rates were calculated by comparing the measured value to the expected amount of Glypican 4 (GPC4) ,etc. by CBA (Cytometric Bead Array) in samples.
| Matrix | Recovery range (%) | Average(%) |
| serum(n=5) | 79-101 | 93 |
| EDTA plasma(n=5) | 98-105 | 102 |
| heparin plasma(n=5) | 87-102 | 94 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Glypican 4 (GPC4) ,etc. by CBA (Cytometric Bead Array) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Glypican 4 (GPC4) ,etc. by CBA (Cytometric Bead Array) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Glypican 4 (GPC4) ,etc. by CBA (Cytometric Bead Array) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Sample | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 91-101% | 81-96% | 89-97% | 95-103% |
| EDTA plasma(n=5) | 80-89% | 97-104% | 87-98% | 79-102% |
| heparin plasma(n=5) | 91-104% | 82-101% | 86-103% | 78-102% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
| Reagents | Quantity | Reagents | Quantity |
Assay procedure summary
1. Add 200μL analysis buffer solution to each well of the plate for pre-wetting;
2. Preparation of standards, reagents and samples before the experiment;
3. Add 100μL standard or sample to each well, add 10μL magnetic beads, and incubate 120 minutes protect from light at 25°C on shaker;
4. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60 minutes protect from light at 25°C on shaker;
5. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent B, and incubate 30 minutes protect from light at 25°C on shaker;
6. Wash plate once on magnetic frame;
7. Add 100μL sheath fluid, swirl for 10 minutes, read on the machine.
GIVEAWAYS
INCREMENT SERVICES
| Magazine | Citations |
| PLoS One. | Identification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation Pubmed:Pmc4072672 |
| Aspects of fluid therapy in the critically ill. Experimental and clinical studies on fluid therapy in the inflammatory conditions. 250690_2_G5_Svajunas_S.pdf | |
| Intensive Care Medicine Experimental | Elevated plasma glypicans are associated with organ failure in patients with infection Pubmed: 30618011 |
| Crit Care | Albumin infusion rate and plasma volume expansion: a randomized clinical trial in postoperative patients after major surgery Pubmed: 31138247 |
| J Endocrinol Invest | Serum glypican4 and glycosylphosphatidylinositol-specific phospholipase D levels are associated with adipose tissue insulin resistance in obese subjects with … Pubmed: 32816247 |
| Heparin Binding Protein and Endothelial Glycocalyx Markers in Severe COVID-19–A Prospective Observational Cohort Study | |
| Sci Rep | Glypican-4 in pregnancy and its relation to glucose metabolism, insulin resistance and gestational diabetes mellitus status 34903856 |
| Catalog No. | Related products for research use of Mus musculus (Mouse) Organism species | Applications (RESEARCH USE ONLY!) |
| RPA998Mu02 | Recombinant Glypican 4 (GPC4) | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA998Mu01 | Recombinant Glypican 4 (GPC4) | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA998Mu01 | Active Glypican 4 (GPC4) | Cell culture; Activity Assays. |
| PAA998Mu02 | Polyclonal Antibody to Glypican 4 (GPC4) | WB; IHC; ICC; IP. |
| PAA998Mu01 | Polyclonal Antibody to Glypican 4 (GPC4) | WB; IHC; ICC; IP. |
| SEA998Mu | ELISA Kit for Glypican 4 (GPC4) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| CMA998Mu | Multiplex Assay Kit for Glypican 4 (GPC4) ,etc. by CBA (Cytometric Bead Array) | FLIA Kit for Antigen Detection. |
| LMA998Mu | Multiplex Assay Kit for Glypican 4 (GPC4) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |

